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Clinical Medicine, University of Oslo, Oslo, NorwayObjective: To assess whether men with reduced semen quality exhibit genetic variants in the genes coding for the messenger RNA
methylation erasers FTO and ALKBH5.
Design: DNA of men undergoing infertility work-up was extracted and the FTO and ALKBH5 genes were sequenced. Statistical
analysis was used to study the correlation between the identiﬁed ALKBH5 and FTO variants and sperm quality.
Setting: University hospital infertility clinic.
Patient(s): Semen samples from 77 unselected men that had been referred to Oslo University Hospital for routine semen analysis as part
of infertility work-up.
Intervention(s): Not applicable.
Main OutcomeMeasure(s): Immunohistochemistry andWestern blot were used to conﬁrm the presence of ALKBH5 and FTO in human
testis. DNA extraction from samples was followed by Illumina MiSeq amplicon high throughput sequencing and sequence alignment.
Variant calling was carried out using GATK's UniﬁedGenotyper. Standard semen parameter analysis was performed according toWorld
Health Organization guidelines.
Result(s): We found an FTO genetic variant to be associated with reduced semen quality. We also identiﬁed two FTOmissense variants,
one mutation (p.Cys326Ser) was located in the important linker between the two protein domains; the other mutation (p.Ser256Asn)
was situated in a ﬂexible loop able to interact with other molecules.
Conclusion(s): The discovery of two missense mutations with potentially detrimental effect on the functionality of the methylation
eraser protein FTO, as well as a genetic variant of the same protein that is associated with altered semen quality could suggest that aber-Use your smartphonerant demethylation of messenger RNA is a factor involved in reduced male fertility. (Fertil Ster-
il 2016;105:1170–9.2016 The Authors. Published by Elsevier Inc. on behalf of the American
Society for Reproductive Medicine. This is an open access article under the CC BY-NC-ND li-
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).)
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1170D uring the past decades,declining sperm counts (1)and increasing incidence of
testicular cancer (2) have increased
concerns about deterioration of human
fecundity (3). Although the causes of
these secular trends remain to be ascer-
tained, impaired sperm quality has been
linked to genetic defects, in utero expo-
sure to environmental pollutants,
obesity, and advanced age (4).
Haploid spermatozoa are produced
from undifferentiated primordial germVOL. 105 NO. 5 / MAY 2016
Fertility and Sterility®cells through an elaborate process involving cell proliferation,
meiosis, and transformation of spermatids to mature sperma-
tozoa. During spermiogenesis, remodeling of chromatin and
consequent termination of transcription necessitates a unique
translational regulation, including synthesis, storage, and de-
layed translation of messenger RNA (mRNA) transcripts (5).
More than 100 structurally distinct RNA modiﬁcations
have been identiﬁed in eukaryotes (6). The most prevalent
of the internal mRNA modiﬁcations is N6-methyladenosine
(m6A), which is distributed nonrandomly in approximately
25% of all transcripts (6, 7). Fluctuations in m6A levels have
been shown to inﬂuence stability, splicing, transport, and
decay of mRNA, affecting meiosis, apoptosis, the length of
the circadian clock, and maintenance of pluripotency (8–13).
We have recently shown that ALKBH5 demethylates
mRNA m6A in vivo (10). Notably, although Alkbh5/ mice
are indistinguishable from their wild-type littermates, we
observed that male Alkbh5/ mice have compromised
fertility. The breeding success rate is remarkably low, the
testes are smaller than wild-type, exhibiting extensive
apoptosis and abnormal tubular anatomy (10). The spermato-
zoa are greatly reduced in number and display severely aber-
rant morphology and reduced motility (10). An additional
AlkB homologue family member, the fat mass and obesity
associated protein (FTO), has been reported to demethylate
mRNA m6A in mammalian cells (14, 15) and FTO-depleted
cells exhibit higher levels of m6A than control cells (11).
We report that the previously observed nuclear speckle
localization of mouse ALKBH5 is conserved for human
ALKBH5 in primary spermatocytes. Intrigued by the subfertil-
ity in Alkbh5/mice, the shared role of ALKBH5 and FTO as
m6A erasers in mRNA, and the intricate RNA processing
during spermiogenesis, we examined whether sequence vari-
ants of the ALKBH5 and FTO genes were related to semen
quality.We sequenced the exons, splice sites, and 50 and 30 un-
translated regions (UTRs) of FTO and ALKBH5 in men under-
going infertility work-up, using the Illumina TruSeq Custom
Amplicon assay and the MiSeq platform (Illumina, Inc.).
Single nucleotide variants and short indels were determined
using GATK's UniﬁedGenotyper and factor analysis was
used to correlate sperm quality parameters with the variants.
We identiﬁed one variant in FTO that is inversely correlated
to semen quality and describe two FTO missense variants.MATERIALS AND METHODS
Testis Protein Extract
Human testicular tissue samples were obtained by percuta-
neous needle biopsy after written informed consent (see sec-
tion on Patient selection and ethical approval). The patients
underwent routine diagnostic procedure for obstructive azoo-
spermia. The samples were stored at 80C before the
experiment. Thawed samples were cut into smaller pieces
with scissors, 0.75 mL of RIPA buffer (0.5% sodium dodecyl
sulfate [SDS], 1% NP40, 1  Complete Protease Inhibitor
[Roche], 0.1 mM phenylmethylsulfonyl ﬂuoride [PMSF] in
phosphate-buffered saline [PBS]) was added to 100 mg of
tissue, and homogenized with a FastPrep-24 instrument
(MP Biomedicals), speed 4 for 30 seconds. The mixture wasVOL. 105 NO. 5 / MAY 2016incubated on ice for 30 minutes and then centrifuged for
30 minutes at 16,900 relative centrifugal force. The superna-
tant containing the whole cell extract was frozen at 80C.Western Blot
Human testis biopsy whole cell extracts were mixed with 10%
1,4-dithiothreitol (Cleland's reagent) (DTT) (1 M), 1  lithium
dodecyl sulfate, and distilled H2O, heat-denatured at 90C for
10 minutes and then cooled on ice. The mixtures containing
10 and 20 mg of protein of whole cell extract were loaded on
a 12% NuPAGE Gel (Life Technologies), electrophorized at
200 V for approximately 45 minutes, and transferred to
a nitrocellulose membrane using a Transblot-Turbo blotter
(BioRad) for 15 minutes. The membrane was blocked at room
temperature for approximately 1 hour in PBST-M (5% milk
in phosphate-buffered saline with 0.05% Tween 20) on a
shaker. Primary anti-FTO antibody (1:3,000 in PBST-M), as
previously reported (14) was added and incubated for 1 hour
at room temperature on a shaker. Three times of 10-minute
PBST washes followed. Secondary horseradish peroxidase-
conjugated goat anti-rabbit antibody (catalogue no. Ab6721,
AbCam) was diluted 1:40,000 in PBST-M and incubated at
room temperature for 1 hour on a shaker. Three times of
10-minute PBST washes followed. The membrane was washed
for 5 minutes in PBS. SuperSignal West Extended Duration
Substrate (ThermoScientiﬁc) was added to the membrane.
The bands were visualized with Gel Doc apparatus (Bio-Rad).Immunoﬂuorescence
Testicular biopsy tissue samples were immediately set in
optimum cutting temperature compound (Sakura), frozen in
liquid nitrogen, and sectioned at 5 mm with a cryotome. Sec-
tions were ﬁxed in cold acetone and exposed to primary
antibodies (anti-ALKBH5 [10], 1:200; normal rabbit IgG,
Santa Cruz, 1:200; anti-SC35, Abcam, 1:50; anti-FTO, Epi-
tomics, 1:1,000; anti-vimentin, Abcam, 1:100) in 1% bovine
serum albumin (BSA)/PBS, followed by ﬂuorochrome-
labeled secondary antibodies (1:1,000) in 10% BSA/PBS.Patient Selection and Ethical Approval
The protocol of the study was approved by the Regional Com-
mittee for Research Ethics (No. 2011/913). We invited 100
consecutive patients to participate and obtained written
informed consent. Patients had been referred to Oslo Univer-
sity Hospital Rikshospitalet for routine semen analysis as part
of infertility work-up. Patients with azoospermia were
excluded for the following reasons: lack of quantitative sperm
parameters for calculating factor analysis; uncertainty
whether the patient had obstructive azoospermia with normal
spermatogenesis or nonobstructive azoospermia with
impaired spermatogenesis, as anamnestic information is not
routinely available to the laboratory at this stage; reduced
DNA quantity and quality in seminal ﬂuid in azoospermia;
if azoospermia cases were retained in the analysis, some vari-
ables would have bimodal distributions; last, we chose to
sequence sperm DNA, thereby excluding patients with azoo-
spermia from the samples that underwent analysis of1171
ORIGINAL ARTICLE: ANDROLOGYALKBH5/FTO variants. Samples were collected during the
period of January 9, 2011 to March 10, 2011. An aliquot of
semen was frozen at80C for DNA extraction. Of the initial
100 patients, 93 met the aforementioned criteria regarding
azoospermia. Due to failures during the sequencing process,
only 77 patients with complete datasets contributed to the
ﬁnal analysis.
Semen Analysis
Semen analysis was performed according to the World Health
Organization guidelines (16) with some modiﬁcations.
Brieﬂy, the ejaculate was collected in sterile sample con-
tainers by masturbation, allowed to liquefy under continuous
shaking at 37C for 30 minutes when volume, pH, and viscos-
ity were measured. Motility of >200 spermatozoa was scored
according to the World Health Organization guidelines on a
phase-contrast microscope ﬁtted with a heated stage and
counting reticle. Sperm concentration was determined in
Neubauer chambers (Improved Neubauer counting chamber,
Karl Hecht) using appropriately diluted samples. The presence
of anti-sperm IgG and IgA antibodies was assessed with the
SpermMAR test (FertiPro). For assessment of sperm
morphology, semen samples were smeared on glass slides,
ﬁxed in ethanol, and stained according to the modiﬁed Papa-
nicolaou procedure. More than 200 spermatozoa were
counted per slide and the presence of defects at the head,
neck, tail, as well as cytoplasmic droplets were recorded ac-
cording to the strict criteria (17). The andrology laboratory
participated in the European Society of Human Reproduction
and Embryology Special Interest Group in Andrology,
(ESHRE)-SIGA, external quality control scheme. Sperm DNA
fragmentation and DNA stainability were assessed by ﬂow
cytometry in permeabilized acid-treated spermatozoa using
acridine orange staining according to the procedure of Even-
son and Jost (18).
Factor Analysis of Semen Parameters
During diagnostic work-up, infertile men routinely undergo
standard semen analysis, which implies assessment of multiple
parameters related to sperm density and function, such as con-
centration, motility, and morphology. We extracted anony-
mized records of 6,049 men who had undergone semen
analysis in our laboratory according to established guidelines
(16). All men in the population of 6,049 had been referred to
spermanalysis aspart of infertilitywork-up.Weexcludedother
referral reasons, including postvasectomy tests, sperm cryo-
preservation before gonadotoxic treatment, repeated sperm
analysis after previously recognized abnormality. We argued
that an unselected sample of patients referred for infertility
work-up will comprise men with varying levels of sperm qual-
ity. When compared to World Health Organization reference
values, 2,740 (45%) patients had normal semen parameters,
whereas 1,936 (32%) had one, 1,002 (16%) two, and 371 (6%)
men had three semen features (concentration, motility, or
morphology) outside the reference range. This prevalence of
sperm defects is comparable to the reported frequency of sperm
analysis abnormalities (31% for one, 18% for two, and 10% for
three abnormal sperm parameters) in subfertile couples (19).1172Sperm parameters obtained from the population sample (n
¼ 6,049) were further processed with factor analysis to
simplify the dataset and derive a single variable that can be
used to assess the association between genotype and sperm
quality. First, we examined correlation among 14 selected
continuous semen parameters and afﬁrmed, as expected,
that the various parameters were closely inter-related
(Supplemental Fig. 1A). Second, we applied factor analysis
to the semen parameters and constructed four independent,
noncorrelating factors from the data (Supplemental Fig. 1B).
These four factors collectively accounted for 54.5%of the total
variance. Maximum-likelihood factor analysis was performed
using the factanal function of R (version 3.1.2; R Foundation
for Statistical Computing). The factor scores were scaled so
that these have normal distribution of mean ¼ 0 and SD ¼ 1
(variance ¼ 1). Negative scores indicated association with
inferior sperm quality (Supplemental Fig. 1B). We also calcu-
lated the mean of factors and argued that mean of factors can
be used to classify patients according to semen quality rather
than relying on measured semen parameters. Third, we per-
formed sensitivity analysis to afﬁrm the contribution of indi-
vidual sperm parameters to factors. We omitted sperm
parameters one-by-one from the dataset, re-run factor anal-
ysis and calculated mean factor scores, which were compared
to the full model using the r2 statistics (Supplemental Fig. 1C).
The association of mean factor scores and sequence variants
was examined with linear regression analysis.
DNA Extraction
Human semen samples were pelleted by centrifugation for
20minutes at 8,000 g and 4C. The pellets were resuspended
in lysis buffer (10 mM Tris-HCl, at pH 8.0, 5 mM ethylenedia-
minetetraacetic acid [EDTA], 1% SDS), DTT was added to a
ﬁnal concentration of 100 mM and the samples were incu-
bated at 37C for 30 minutes. RNase A (100 mg) was added
and the samples were again incubated at 37C for 30 minutes.
Proteinase K was added to a ﬁnal concentration of 1 mg/mL.
The samples were then incubated at 55C overnight on a
shaker. Genomic DNA was extracted with Qiagen Blood and
Tissue kit (Qiagen) according to manufacturer's instructions.
The DNA was stored at 80C and delivered for sequencing
at a concentration of 50 ng/mL and a volume of 12 mL.
Sequencing and Variant Calling
We used the Illumina MiSeq amplicon technology at the
sequencing facility at Radiumhospitalet in Oslo, Norway, to
identify germ-line variants inALKBH5 and FTO (see schematic
overview in Supplemental Fig. 2). Primers were designed to
generate amplicons covering the exonic regions aswell as parts
of the UTRs (Supplemental Fig. 3); the primer sequences and
the targeted genomic regions can be found in Supplemental
Tables 1 and 2. Sequence alignments were made using the Illu-
mina TruSeq Custom Amplicon workﬂow, using a banded
Smith-Waterman algorithm. Single nucleotide variants and
short indels were determined using GATK's UniﬁedGenotyper
(version 3.2.3), using the following nondefault options:
max_alternate_alleles¼2, standard_min_conﬁdence_
threshold_for_emitting¼10 (minimum phred-scaledVOL. 105 NO. 5 / MAY 2016
Fertility and Sterility®conﬁdence threshold at which variants should be emitted),
genotype_likelihoods_model¼BOTH (single nucleotide
polymorphisms and indels). To reduce the number of false
positives among the identiﬁed variants, we set up a hard ﬁl-
ter of genotypes according to GATK's best practices (geno-
types that were kept needed the following GATK genotype
scores: QualByDepth >2.0, FisherStrand <60.0, RMSMap-
pingQuality >40, MQRankSum > 12.5, ReadPosRankSum
>8). Heterozygotes in which the read fraction of the alter-
native allele was <20% were also discarded as false
positives.
To interpret the functional role of identiﬁed variants, we
implemented a functional annotation pipeline of genomic
variants. This included ANNOVAR—August 2014 release
(20) for consequence type with respect to gene-coding re-
gions (using RefSeq as the model database for human
genes/proteins), PFAM version 27.0 (21) for overlap with
functional protein domains, UniProt Knowledge base (22)FIGURE 1
FTO and ALKBH5 are N6-methyladenosine RNA demethylases present in hum
activity of methyltransferases METTL3 and METTL14 using S-adenosyl met
FTO and ALKBH5 using dioxygen, ferrous iron, and a-ketoglutarate (O2-Fe
extract (WCE) with FTO antibody, numbers indicate molecular weigh
Immunoﬂuorescence image of human testis section stained with 6-diami
Scale bar, 10 mM. (D) Immunoﬂuorescence image of human testis biopsy
nuclear speckle protein SC35. Lower images: IgG as negative control. Scal
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VOL. 105 NO. 5 / MAY 2016for overlap with active and functional sites within proteins,
dbNSFP version 2.6 (23) for computational predictions of
phenotypic effects of missense variants, and dbSNP version
142 (24) for overlap with previously reported germ-line
variants. We also checked for overlap with 1000Genomes
Project phase3 (1000 Genomes Project Consortium 2010)
and the ExAC database (Exome Aggregation Consortium
2015) for population-speciﬁc allele frequencies of
germ-line variants.RESULTS
FTO and ALKBH5 are Present in the Human Testis
RNA adenine is methylated by methyltransferases, and the re-
sulting m6A base can be converted back to adenine by deme-
thylases. Two mRNA m6A demethylases are known to date,
FTO and ALKBH5. These use dioxygen, ferrous iron, and
a-ketoglutarate as cofactors (Fig. 1A). We wanted to conﬁrman testis. (A) Adenine is converted to m6adenine through the catalytic
hionine. m6adenine is converted back to adenine by the demethylases
(II)/a-KG) as cofactors. (B) Immunoblotting of human testis whole cell
t in kilodaltons. Lane 1, 10 mg WCE; lane 2, 20 mg WCE. (C)
no-2-phenylindole (DAPI) and antibodies targeting FTO and vimentin.
section stained with DAPI and antibodies targeting ALKBH5 and the
e bar, 10 mM.
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testis. To this end, whole cell extract from human testis was
immunoblotted against FTO, and a speciﬁc bandwas obtained
at 58 kDa corresponding to the expected molecular weight of
the FTO protein (Fig. 1B). In addition, immunoﬂuorescence
staining of human testis sections for FTO detected FTO in
the testis, with a stronger signal in the Sertoli cells (Fig. 1C).
The presence of ALKBH5 in human testis was conﬁrmed using
immunoﬂuorescence staining of sectioned biopsy samples.
ALKBH5 is primarily localized to the nucleus and colocalizes
with the nuclear speckle marker SC35 in primary spermato-
cytes (Fig. 1D). The presence of primary spermatocytes was
afﬁrmed in adjacent sections by typical pattern of 6-
diamino-2-phenylindole (DAPI)-stained nuclear material
and cells' position within the seminiferous tubules. Normal
rabbit IgG was used as a negative control.Identiﬁcation of Sequence Variants in the ALKBH5
and FTO Genes
To identify sequence variants of ALKBH5 and FTO, we re-
cruited 77 unselected menwho were referred to semen analysis
as part of infertility work-up. Patients gave written informed
consent and delivered a semen sample that was analyzed ac-
cording to routine procedures. Semen quality factors were
calculated as described in the Materials and Methods section.
Based on the distribution of the mean of factors, this sample
of 77 men was representative of the total population of 6,049
men undergoing infertility work-up at our clinic
(Supplemental Fig. 4). The men were invited to the study
consecutively, ensuring an unbiased random recruitment,
and the distribution of the mean factor scores in the sample
of 77 men ﬁtted well with the factor score distribution of the
whole population of 6,049 men (Kolmogorov-Smirnoff test,
P¼ .79), indicating that sperm quality was comparable.
Genomic DNA extracted from the semen samples was puriﬁed
and sequenced. The sequencing scheme involvedmultiplex po-
lymerase chain reaction (PCR), high-throughput sequencing,
mapping and variant identiﬁcation, as outlined in
Supplemental Figure 2. Sequencing of selected regions of the
ALKBH5 and FTO genes identiﬁed 33 sequence variants, 21
were found in the ALKBH5 gene and 12 in the FTO gene
(Table 1). One variant upstream of the FTO transcription start
site overlapped an intron of RPGRIP1L. Of all the identiﬁed
variants, 29 were previously reported in the dbSNP database
(24). The four variants that were not previously reported in
dbSNP consisted of three short deletions (all located in the
UTR of FTO), and one single nucleotide variant (FTO coding re-
gion). With respect to protein-coding changes, we identiﬁed
two missense variants in the FTO gene (p.Ser256Asn and p.Cy-
s326Ser), each occurring once in the sample cohort. Missense
variants generate a modiﬁed amino acid sequence in the ex-
pressed FTO protein. Although p.Cys326Ser was not reported
in dbSNP, we discovered that it was recorded as a very rare
allele in the Exome Aggregation (ExAC) database, with an esti-
mated global population frequency of 0.0001 (25). The other
missense variant (p.Ser256Asn) was also present in the ExAC
database, with an estimated global population frequency of
0.002. Both protein-coding variants were thus generally rare1174in the global population. Of the variants found in the ALKBH5
gene, the majority were located in the 30 UTR (Table 1).Association Between Variants and Semen Quality
The group of 77 men was arranged by increasing semen qual-
ity based on the mean of factors (Fig. 2). Association among
sequence variants of ALKBH5 and FTO and the mean of fac-
tors was assessed by linear regression analysis. The FTO single
nucleotide variant rs62033438, carried by 48 samples, is an
intronic variant that was found to be signiﬁcantly associated
with semen quality (P¼ .001), suggesting that the presence of
the wild-type (A) compared with the variant (G) nucleotide
was related to inferior semen quality (Table 1). Of the
sequenced patients, 29 exhibited genotype A/A, 38 exhibited
genotype G/A, and 10 exhibited genotype G/G. Sperm con-
centration, total sperm count, normal DNA stainability,
normal sperm morphology, and rapid progressive motility
were positively associated with the presence of G/G or G/A
genotype in rs62033438 (Supplemental Fig. 5).Protein Structure Analysis of Missense Mutations
in FTO
As mentioned previously, two rare missense mutations were
identiﬁed in the FTO gene: p.Ser256Asn and p.Cys326Ser
(Fig. 3). The three-dimensional structure of human FTO can
be found in the Protein Data Bank under the accession code
3LFM (26). This crystallized structure is an amino terminally
truncated (by 31 residues) version of the human FTO protein
bound to the mononucleotide 3-meT (26). The three-
dimensional structure of human FTO contains Fe2þ, a bound
nucleotide and an a-ketoglutarate analogue. Residues 251–
263 form a loop that is not visible in the X-ray structure
because it is structurally disordered and ﬂexible, and does
not fold into a regular three-dimensional structure. The loop
is, however, highly accessible and able to interact with other
macromolecules and molecular surfaces. The missense muta-
tion p.Ser256Asn, which we observed in the germ line of a pa-
tient, is located in the middle of this loop. The structure
comprises an amino-terminal a-ketoglutarate-dependent di-
oxygenase domain and a carboxy-terminal domain that ap-
pears to be unique to FTO. The p.Cys326Ser variant is
located in the very middle of the linker between these two
domains.DISCUSSION
Although the male factor is a contributing cause in about 50%
of infertile couples, the determinants of impaired semen qual-
ity, especially the genetic causes, often remain undiagnosed
(27). In addition to chromosome abnormalities and single
gene defects in rare and severe cases of male sterility (28),
more common gene polymorphisms also affect fertility (29).
In the present study, by combining deep sequencing and
robust statistical analysis, we explored whether sequence var-
iants of ALKBH5 and FTO genes, which are involved in RNA
processing and spermatogenesis in mice, were associated with
semen quality in humans.VOL. 105 NO. 5 / MAY 2016
TABLE 1
Sequence variants of ALKBH5 and FTO, variant frequency, and association with semen quality.
Variant symbol Locus Genomic position (GRCh37) Variant class Alleles Amino acid change Variant type
Genotype frequencya
Association with semen
quality (P value)0/0 0/1 1/1
rs78123366 ALKBH5 Chr17:18086495 Snv G/A Upstream gene variant 76 1 0 1.95E-01
rs552236280 ALKBH5 Chr17:18086570 Snv C/T Upstream gene variant 75 2 0 8.74E-01
rs558358916 ALKBH5 Chr17:18086716 Snv A/G Upstream gene variant 76 1 0 4.47E-01
rs146551631 ALKBH5 Chr17:18086951 Snv G/A 50 UTR variant 76 1 0 1.27E-01
rs1064629 ALKBH5 Chr17:18087299 Snv C/T 50 UTR variant 58 17 2 6.73E-01
*087513b ALKBH5 Chr17:18087513 Indel TGCCCCGCCC/T 50 UTR variant 76 1 0 3.39E-02
rs11078411 ALKBH5 Chr17:18088094 Snv C/T p.H179H Synonymous variant 72 2 3 4.73E-01
rs1563371 ALKBH5 Chr17:18111793 Snv C/T 30 UTR variant 45 29 3 7.31E-01
rs142135062 ALKBH5 Chr17:18111802 Indel GTTTTTGT/G 30 UTR variant 35 29 13 7.95E-01
rs1378602 ALKBH5 Chr17:18111868 Snv G/A 30 UTR variant 14 36 27 7.65E-01
rs181356656 ALKBH5 Chr17:18111980 Snv G/A 30 UTR variant 76 1 0 4.37E-01
rs570534770 ALKBH5 Chr17:18111998 Snv A/C 30 UTR variant 76 1 0 6.20E-01
rs13284 ALKBH5 Chr17:18112130 Snv C/T 30 UTR variant 45 29 3 7.31E-01
*112369b ALKBH5 Chr17:18112369 indel GC/G 30 UTR variant 76 1 0 3.00E-01
rs113683457 ALKBH5 Chr17:18112432 Snv A/G 30 UTR variant 70 7 0 7.85E-01
rs3088233 ALKBH5 Chr17:18112675 Snv C/T 30 UTR variant 45 29 3 7.31E-01
rs4925146 ALKBH5 Chr17:18112720 Snv G/T 30 UTR variant 76 1 0 1.27E-01
rs199923993 ALKBH5 Chr17:18112836 indel AATAAT/A 30 UTR variant 76 1 0 7.95E-01
rs8400 ALKBH5 Chr17:18112845 Snv G/A 30 UTR variant 3 18 56 6.08E-01
rs116946161 ALKBH5 Chr17:18113027 Snv G/A 30 UTR variant 76 1 0 7.95E-01
*113162b ALKBH5 Chr17:18113162 indel A/AT 30 UTR variant 1 76 0 3.39E-02
rs62048369 FTO Chr16:53737560 Snv G/A Intron variant 74 3 0 4.05E-01
rs3826169 FTO Chr16:53860481 Snv G/A Intron variant 7 27 43 9.60E-01
rs144743617 FTO Chr16:53878082 Snv G/A p.S256N Missense variant 76 1 0 8.71E-02
rs62033438 FTO Chr16:53878247 Snv A/G Intron variant 29 38 10 1.04E-03
rs143719235 FTO Chr16:53913678 Snv T/C Intron variant 75 2 0 6.52E-01
*913756b FTO Chr16:53913756 Snv T/A p.C326S Missense variant 76 1 0 5.14E-01
rs552126057 FTO Chr16:54145602 Snv C/T Intron variant 76 1 0 8.24E-01
rs5816925 FTO Chr16:54147206 indel CG/C 30 UTR variant 13 35 29 6.00E-02
rs147409759 FTO Chr16:54148007 Snv G/T 30 UTR variant 75 2 0 7.34E-01
rs117637522 FTO Chr16:54148037 Snv A/A 30 UTR variant 76 1 0 1.95E-01
rs79234192 FTO Chr16:54148128 Snv G/A 30 UTR variant 76 1 0 9.92E-01
rs45564131 FTO Chr16:54148189 Snv A/AT 30 UTR variant 75 2 0 7.34E-01
Note: indel ¼ insertion/deletion variant; Snv ¼ single nucleotide variant.
a 0/0 ¼ wild-type reference allele (monomorphic); 0/1 ¼ heterozygous alternative allele; 1/1 ¼ homozygous alternative allele.
b Variants not previously reported in the dbSNP database.
Landfors. Sequencing of FTO and ALKBH5 variants. Fertil Steril 2016.
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FIGURE 2
Correlation between sequence variants of ALKBH5 and FTO and semen quality. Men, who are not azoospermic, undergoing infertility work-up
(n ¼ 77) are grouped by increasing semen quality as deﬁned by the mean of four independent factors established by factor analysis on the
larger population (top: red-blue scale indicates factor scores). Illumina MiSeq sequencing of selected regions of ALKBH5 and FTO identiﬁes 33
sequence variants. Bottom right: white, gray, and black indicate wild-type, heterozygote, and homozygote variant genotypes, respectively.
Presence of variant rs62033438 is signiﬁcantly associated with semen quality (linear regression, uncorrected P¼.001; dashed line indicates level
of Bonferroni-corrected a<0.05).
Landfors. Sequencing of FTO and ALKBH5 variants. Fertil Steril 2016.
ORIGINAL ARTICLE: ANDROLOGYThe transformation of the spermatids during spermiogen-
esis comprises a condensation of nuclear DNA. This compli-
cated process involves a wave of transcription that
generates mRNAs needed during later stages when transcrip-
tion has been largely shut down due to inaccessible DNA. This
distinct mRNA processing is vital for the accurate progression
of the spermiogenesis (30).
Proper regulation of the mRNA methylation level is
essential for cellular function, demonstrated by the fact that
depletion of methylating or demethylating enzymes both
result in apoptosis (10, 31). Nonstoichiometric distribution
along the mRNA transcripts, absence in poly(A) tails, a
consensus sequence that is conserved across kingdoms, and
differences in abundance between tissues, strongly suggest
a regulated, functional role for m6A (15, 32). At present,
two m6A demethylating enzymes have been identiﬁed,
ALKBH5 and FTO. They belong to the human AlkB
homologue family of nonheme iron- and a-ketoglutarate-
dependent dioxygenases (33, 34). Depletion of these
enzymes results in higher m6A levels (10, 11).1176The importance of proper methylation of mRNA for
meiosis and development has been shown in a number of re-
ports. m6A methylation plays a critical role in yeast meiosis
with impaired meiotic progression occurring as a result of
compromised methylation activity (8). Disruption of the
m6A methylating agent in Arabidopsis thaliana leads to em-
bryo lethality (32) and methylating components in
Drosophila melanogaster have been shown to be essential
for oogenesis (35).
Consistent with the ﬁnding that aberrant m6A processing
compromises meiosis, mice deﬁcient in ALKBH5 displayed
spermatogenic maturation arrest (10). Expression of Alkbh5
has been detected in all mouse organs tested; the highest
expression was found in testis (10). The mRNA nuclear export
is greatly affected in ALKBH5-deﬁcent cells with a signiﬁcant
shift in mRNA localization from the nucleus to the cytoplasm.
It appears to be the demethylating ability of ALKBH5 that
causes this shift (10). Extensive cell death through apoptosis
was discovered in the testes of Alkbh5/ mice (10). In the
testes of wild-type mice, ALKBH5 colocalizes with splicingVOL. 105 NO. 5 / MAY 2016
FIGURE 3
Structure of FTO with positions of observed missense mutations,
variants rs144743617 and *913756 indicated. The crystallized
three-dimensional structure of human FTO comprises an amino
terminal a-ketoglutarate-dependent dioxygenase domain (salmon)
and a carboxyl terminal domain that appears to be unique to FTO
(cyan). The structure also contains Fe2þ (orange ball), a bound
nucleotide (green), and an a-ketoglutarate analogue (salmon, red,
and blue sticks). Variant rs144743617: mutation p.Ser256Asn.
Residues 251–263 form a ﬂexible loop that is not visible in the
X-ray structure (dashed line). Residues 249 and 250 as well as
residues 264 and 265 ﬂank the loop and are depicted in blue.
Residue Ser256 is located in the middle of this loop (red circle).
Variant *913756: mutation p.Cys326Ser. Residue 326 (black circle)
is located exactly in the middle of the linker between the two FTO
domains. Protein Data Bank, accession code 3LFM (Han et al.
2010). The protein illustrations were generated with PyMOL (http://
www.pymol.org).
Landfors. Sequencing of FTO and ALKBH5 variants. Fertil Steril 2016.
Fertility and Sterility®proteins in nuclear speckles where storage and pre-mRNA
processing occurs and is speciﬁcally expressed in primary
spermatocytes (10, 36). We show here that human testes
display the same pattern of expression: ALKBH5 is
expressed in the testes and appears to be speciﬁcally present
in primary spermatocytes where it colocalizes with the
nuclear speckle marker SC35. This conservation is
underpinning the plausibility of a conserved functional role
of ALKBH5 in human spermatogenesis.
Both in murine and human tissue samples FTOwas found
to be widely expressed in fetal and adult tissues, with highest
expression in the brain, particularly the hypothalamus
(37, 38). FTO has repeatedly been shown to be localized to
the nucleus (38, 39); however, a cytoplasmic fraction might
also exist (40). Similarly to the Alkbh5/ mice, Fto
knockout mice exhibit severely reduced fertility (Ulrich
R€uther, Heinrich-Heine-University, D€usseldorf, Germany,
unpublished data). We conﬁrmed the expression of FTO in hu-
man testis; this is consistent with previous ﬁndings (The Hu-
man Protein Atlas, www.proteinatlas.org [41]). Considering
that the localization of m6A in the mRNA fragments is highly
conserved between mice and humans (31), and that a shift in
the m6A levels in Alkbh5/ mice seems to adversely affect
spermatogenesis, a malfunctioning FTO protein may also
affect fertility.
Although there is evidence for low levels of late transcrip-
tional activity during spermiogenesis (42, 43), the bulk of theVOL. 105 NO. 5 / MAY 2016mRNA of spermiogenesis-speciﬁc proteins are transcribed
early during spermatogenesis and stored as translationally
repressed mRNAs that are translated in elongating spermatids
(30, 44). The repressed mRNAs are stored and processed in a
germ cell-speciﬁc cellular structure called the chromatoid
body (44). The chromatoid body has been described to share
a number of signiﬁcant similarities with the processing
body (P-body) and function as a sorting center for mRNAs
in male germ cells (44, 45). It has been shown that m6A is
recognized by the human YTH domain family 2 protein
(YTHDF2) and that this methylation-dependent interaction
leads to the bound mRNA, localizing to sites of mRNA decay
such as the P-body (46). This poses the question whether
mRNA is transported to the chromatoid body in a similar
way and that this process could be disturbed by the lack or
reduced presence of demethylating proteins. The proteins
necessary for the later steps in spermiogenesis, including ﬂa-
gellum formation, must be synthesized and stored before the
event takes place. Defects in the storage or processing of the
corresponding mRNAs could therefore impact the efﬁciency
and accuracy of the morphological change, including tail
development. The spermatozoa of ALKBH5 deﬁcient mice
exhibit morphological defects including tail abnormalities.
Notably, spermmorphological defects are exceptionally prev-
alent in infertile men (47).
Of the 21 variants identiﬁed in theALKBH5 gene, 14 were
localized to the 30 UTR. The 30 UTR is one of the major gene-
regulating regions (48). The 30 UTRs contain binding sites for
micro RNAs, as well as a large number of regulatory proteins
(48). There are indications that the length of the 30 UTR is an
important factor in mRNA expression with longer regions
having a higher probability of containing regulatory sites
that impact translation (48). The 30 UTR of human ALKBH5
is1,555 nucleotides long (http://www.ncbi.nlm.nih.gov/IEB/
Research/Acembly/av.cgi?exdb¼AceView&db¼36a&term¼
ALKBH5). This exceeds the average mammalian 30 UTR of
approximately 1,000 nucleotides (49–51). The numerous
variants found in the 30 UTR of our patients could reﬂect a
change in the processing of the ALKBH5 mRNA due to
misfolded secondary structures, or disruption of sites for
micro RNAs or RNA-binding proteins.
Both FTO and ALKBH5 have been reported to contain the
double-stranded b-helix fold typical for their protein family,
as well as structures that convey selectivity toward single-
stranded nucleotide substrates (26, 38, 52). Human FTO
consists of an amino-terminal a-ketoglutarate-dependent di-
oxygenase domain (residues 1–326) and a carboxy-terminal
domain (residues 327–505). The latter appears to be unique
to FTO, not sharing signiﬁcant homology with any known
structures (26).
In the present study we discovered two missense variants
in the FTO gene in germ line DNA from two patients. At amino
acid position 256 a serine residue has been replaced by an
asparagine (p.Ser256Asn). Residues 251–263 form a loop
that is not visible in the X-ray structure because it is structur-
ally disordered and ﬂexible, and does not fold into a regular
three-dimensional structure. The missense mutation
p.Ser256Asn is located in the middle of this loop. Ser256 is
conserved in placental mammals, implying a conserved1177
ORIGINAL ARTICLE: ANDROLOGYfunction. The variant has been described before and shown
not to be correlated to obesity (53). In placental mammals,
the region corresponding to human FTO residues 250–260 is
highly enriched in negatively charged residues, Glu and
Asp, as well as Gly and Pro. It is highly accessible and able
to interact with other macromolecules, positively charged
surfaces or similar. The change from one polar amino acid res-
idue to another might not affect the charge of the residue;
however, the accessibility of the residue to other macromole-
cules enables protein modiﬁcations, such as phosphorylation
and glycosylation, that could be inﬂuenced by a residue
change. The patient carrying the variant S256N had normo-
zoospermia (concentration 107 M/mL, progressive motility
56%, normal forms >7%, high DNA stainability 5%). The pa-
tient had proven fertility.
The second missense variant identiﬁed in the present
study is at amino acid position 326. A cysteine residue that
has been replaced by a serine (p.Cys326Ser). p.Cys326 is
located exactly in the middle of the linker between the two
main FTO domains and is conserved in all mammals. The
side-chain does not appear to interact with any other parts
of the protein, at least not in the ﬁnal, folded protein.
Cys326 is not close to the active site or to the entrance to
the active site pocket. There is extensive interaction between
the two main domains of the FTO protein. This interaction is
required for FTO catalytic activity (26). It has been suggested
that the carboxyl domain stabilizes the conformation of the
catalytically active amino domain (26). Interestingly, muta-
tions that have been suggested to alter the interaction be-
tween the carboxy- and the amino-terminal domains. They
have been shown to markedly reduce FTO activity (26). In
an enzyme where the interaction between the two main do-
mains is crucial for the activity of the protein, a change in
the linker between these domains, as observed in our study,
could have a profound effect on protein function. A homozy-
gote loss-of-function mutation is not likely to be found, as
loss-of-function mutations in humans have been reported
to result in a severe phenotype of microcephaly, functional
brain deﬁcit, and psychomotor delay. The afﬂicted individ-
uals do not survive the age of 30 months (54). The patient
with variant C326S had isolated teratozoospermia (concen-
tration 26 M/mL, progressive motility 41%, normal forms
1%, high DNA stainability 33%). We reviewed the patient's
archived sperm smear and saw variable, grossly irregular
head morphology, such as spermatozoa with irregular head
shape, increased nuclear staining, irregular acrosome, exfoli-
ated irregular germ cells, and occasionally double-headed or
double-tailed spermatozoa indicating meiotic nondisjunc-
tion. Nonetheless, these morphological derangements are
frequently seen in abnormal sperm smears and fail to deﬁne
a distinct disease picture. The patient delivered two sperm
tests with similar results, but the couple has not followed up
the ﬁndings in our clinic. Further biochemical analysis should
focus on assessing the degree of enzymatic functionality of
these missense FTO variants.
The variant identiﬁed in the FTO gene that is associated
with semen quality is an intronic variant. It is unlikely that
an intronic variant changes the capability of the translated
protein. However, intronic variants in the FTO gene have1178been shown to have an impact on the promoters of at least
one other gene through long-range looping (55). Also, single
nucleotide variants might not lead to functional mutations
but could cause a shift in the transcription of the gene. Of
the numerous gene polymorphisms implicated in male factor
infertility, those affecting the AZF and theMTHFR have been
independently conﬁrmed to have clinical impact (56). Further
studies are required to elucidate the functional mechanism
causing an FTO variant to be associated with altered semen
quality.
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SUPPLEMENTAL FIGURE 1
Reduction of highly correlated semen parameters with factor analysis. (A) Correlation matrix reveals multiple close correlations among semen
parameters in men who are not azoospermic undergoing infertility work-up (n ¼ 6,049). Color scale, Pearson's correlation coefﬁcient. Conc ¼
sperm concentration (million/mL); CytoDrop ¼ presence of cytoplasmic droplets (%); DFI ¼ DNA fragmentation index; HDS ¼ high DNA
stainability; HeadDef ¼ irregular head morphology (%); NeckDef ¼ irregular neck morphology (%); NormalMorph ¼ sperm with normal
morphology; ProgMot ¼ progressive motile sperm (%); RapidProg ¼ rapid progressively motile sperm (%); TailDef ¼ irregular tail morphology
(%); TotalCount ¼ total sperm count (million); TZI ¼ teratozoospermia index; Vol ¼ volume (mL). (B) From 14 measured semen parameters,
factor analysis extracts 4 unobserved, independent variables, also called factors, as linear combination of semen parameters. Here, linear
coefﬁcients, also called factor loadings, are plotted for each semen parameter. (C) Mean factor scores derived after omitting sperm parameters
one-by-one were compared with the full model using the r2 statistics. Omission of sperm parameters with large impact on factor analysis (e.g.,
concentration) yields models with low agreement with the models based on all parameters. Sensitivity analysis indicates that the factor was
dominated by sperm concentration values, whereas the independent inﬂuence of chromatin parameters (DFI, HDS) was low.
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SUPPLEMENTAL FIGURE 2
Schematic overview of sequencing design. Amplicons were designed to cover the exonic regions, splice sites and parts of the untranslated (UTR)
regions. Sequencing was carried out using the Illumina MiSeq platform and variants were called with GATK's UniﬁedGenotyper. Red circles
illustrate identiﬁed variants. PCR ¼ polymerase chain reaction.
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SUPPLEMENTAL FIGURE 3
Ampliﬁed regions of FTO and ALKBH5with variant positions. In 77 men undergoing infertility work-up, we sequenced selected regions of ALKBH5
and FTO, located on chromosomes 17 and 16, respectively (bottom). Appropriate primers were designed to cover the 50 and 30 untranslated
regions, exons, and neighboring intronic regions of ALKBH5 and FTO (gene models, blue arrow), and the ampliﬁed regions (red arrow) were
sequenced on the Illumina MiSeq platform. The presence of sequence variants (dots) was related to semen quality using linear regression.
Variant rs62033438 (red circle), located within the fourth intron of the FTO gene, achieved statistically signiﬁcant association with semen
quality (P¼.00103; dashed line indicates Bonferroni-corrected a<0.05).
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SUPPLEMENTAL FIGURE 4
The group of men (n¼ 77) examined for genomic variants of ALKBH5
and FTO is representative of the population of men who are not
azoospermic (n ¼ 6,049). Factor analysis was used to extract 4
unobserved independent factors from 14 measured semen
parameters in 6,049 men undergoing infertility work-up. The red
line indicates population distribution of factor scores. The factor
analysis model established in the larger population was
subsequently applied to the sample of 77 men, and it resulted in
indistinguishable sample distribution of factor scores (bar chart;
Kolmogorov-Smirnov test, P¼.79).
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SUPPLEMENTAL FIGURE 5
Association between semen parameters and the presence of FTO variant rs62033438. Semen parameters of menwho are not azoospermic (n¼ 77)
are grouped according to the strength of associationwith the presence of rs62033438 variant. Uncorrected P value, linear regression analysis. Conc
¼ sperm concentration (million/mL); CytoDrop ¼ presence of cytoplasmic droplets (%); DFI ¼ DNA fragmentation index; HDS ¼ high DNA
stainability; HeadDef ¼ irregular head morphology (%); NeckDef ¼ irregular neck morphology (%); NormalMorph ¼ sperm with normal
morphology; ProgMot ¼ progressive motile sperm (%); RapidProg ¼ rapid progressively motile sperm (%); TailDef ¼ irregular tail morphology
(%); TotalCount ¼ total sperm count (million); TZI ¼ teratozoospermia index; Vol ¼ volume (mL). Boxes bottom right: the observed variant A/A
(white); heterozyogte A/G (light gray); wild-type G/G (dark gray). Box plot explanation: upper horizontal line of box, 75th percentile; lower
horizontal line of box, 25th percentile; horizontal bar within box, median; upper horizontal bar outside box, 90th percentile; lower horizontal
bar outside box, 10th percentile. Circles represent outliers.
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